Drugmakers stockpile inventory in the US, seeking to get ahead of Trump tariffsnews2025-04-22T14:00:06+00:00April 22nd, 2025|Endpoints News|
Roche promises $50B investment in the US as pharma tariffs inch closernews2025-04-22T10:38:39+00:00April 22nd, 2025|Endpoints News|
US drugs rely heavily on ingredients made overseas — reportnews2025-04-17T15:14:23+00:00April 17th, 2025|Endpoints News|
Bayer opens $44M US expansion; Meribel CDMO launches in Europenews2025-04-17T14:34:55+00:00April 17th, 2025|Endpoints News|
Biotech, CDMOs start to disclose tariff exposure with US trade inquiry underway news2025-04-16T12:43:58+00:00April 16th, 2025|Endpoints News|
J&J CEO chides Trump’s tariff plan to boost US drugmakingnews2025-04-15T18:53:47+00:00April 15th, 2025|Endpoints News|
Trump’s pharma probe sweeps in APIs, ‘key starting materials’news2025-04-15T16:54:42+00:00April 15th, 2025|Endpoints News|
Trump drug tariffs inch closer as Commerce Department launches 232 investigationnews2025-04-14T22:27:27+00:00April 14th, 2025|Endpoints News|
Pharma tariffs to arrive ‘in the next month or two,’ commerce secretary saysnews2025-04-14T11:00:54+00:00April 14th, 2025|Endpoints News|
CDMOs anticipate inspection bottlenecks after FDA firingsnews2025-04-11T13:18:17+00:00April 11th, 2025|Endpoints News|
